Glooko Stock

glooko.comHealthcare / Other HealthcareFounded: 2010Funding to Date: $71MM

Glooko is a provider of digital health solutions designed for people with chronic conditions like diabetes and obesity and their healthcare professionals, enabling telehealth, clinical research, and improved collaboration.

Register To Buy and Sell Shares

For more details on financing and valuation for Glooko, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Glooko’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Glooko.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Stephen Lien
Chief Financial Officer
Michael Greenfield MD
Chief Medical Officer
Annie Wayne
Chief Financial Officer
Russ Johannesson
Chief Executive Officer
David Conn
Chief Commercial Officer

Board Members

Chamath Palihapitiya
Social Capital
Vint Cerf Ph.D
Yogen Dalal Ph.D
Brendon Kim
Samsung NEXT Ventures
Theodore Maidenberg
Social Capital
William Campbell
Russell Hirsch Ph.D
Sundeep Madra
Xtreme Labs
Wende Hutton
Canaan Partners

Frequently Asked Questions About Glooko’s Stock

plusminus
Can you buy Glooko’s stock?
Glooko is not publicly traded on NYSE or NASDAQ in the U.S. To buy Glooko’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Glooko’s stock?
Yes, you can sell stock of a private company like Glooko. Forge can help you sell your Glooko stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Glooko’s stock price?
Glooko is a privately held company and therefore does not have a public stock price. However, you may access Glooko’s private market stock price with Forge Data.
plusminus
What is Glooko’s stock ticker symbol?
Glooko does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Diabetes company Glooko partners with insulin dosing app Hedia
Diabetes management firm Glooko is partnering with Denmark-based Hedia to incorporate its app into Glooko's remote monitoring platform. The Hedia Diabetes Assistant app, which gives bolus insulin dosing advice, will sync with Glooko's platform, allowing patients to share their diabetes data with healthcare providers. The integration is expected to launch in Europe in Q4 2023 and Q1 2024.
Glooko, Sanofi partner on insulin pen connectivity
Glooko and Sanofi have partnered to incorporate a connected device for insulin pens into Glooko's digital platform. The SoloSmart device works with Sanofi’s insulin injection pens and records the insulin dose, date and time of injection. This data can then be visualised on the Glooko app and shared with healthcare professionals for improved diabetes management. Sanofi plans to utilise Glooko's global presence in over 8,000 clinics to increase digital solutions accessibility. SoloSmart is not yet approved for marketing in the U.S.
Updated on: Apr 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.